Hyperekplexia mutation of glycine receptors: decreased gating efficacy with 
altered binding thermodynamics

Maksay, G.; Biró, T.; Laube, B.

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

Hyperekplexia mutation of glycine receptors: decreased gating efficacy with altered binding thermodynamics

MPS-Authors

/persons/resource/persons208089

Maksay, G.
Neurochemistry Department, Max Planck Institute for Brain Research, Max Planck Society;

/persons/resource/persons208072

Laube, B.
Neurochemistry Department, Max Planck Institute for Brain Research, Max Planck Society;

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Maksay, G., Biró, T., & Laube, B. (2002). Hyperekplexia mutation of glycine receptors: decreased gating efficacy with altered binding thermodynamics. Biochemical Pharmacology, 64(2), 285-288.

Cite as: https://hdl.handle.net/11858/00-001M-0000-002E-1C21-9

Abstract

[H-3]Strychnine binding was studied to recombinant human alpha(1) and the hyperekplexia mutant alpha(1)R271L glycine receptors (GlyRs) transiently expressed in human embryonic kidney (HEK)-293 cell cultures at 0, 18 and 37. The alpha(1)R271L mutation did not affect the linear van't Hoff plots of the exothermic binding of the antagonist [H- 3]strychnine while it turned taurine into an antagonist with exothermic binding. The inhibition constants of the agonist glycine showed opposite temperature dependence on alpha(1) GlyRs, corresponding to endothermic binding driven by large entropic increases. The temperature dependence of displacement by the partial agonists taurine on a, GlyRs and glycine on alpha(1)R271L GlyRs was biphasic reflecting negative heat capacity changes, dehydration changes and/or a complex binding mechanism. The thermodynamic discrimination of efficacy is valid for native rat spinal and recombinant human GlyRs. The alpha(1)R271L mutation impairs the transduction mechanism and distorts gating of GlyRs. Thereby it reduces the potency and efficacy of agonists and affects their thermodynamic parameters of binding. The hyperekplexia mutation offers a model system to demonstrate the correlation among pathophysiology, gating efficacy and binding thermodynamics of GlyRs. (C) 2002 Elsevier Science Inc. All rights reserved.